Diverse studies have linked cystatin C to chronic conditions such as end stage renal disease (Mantri et al., 2019), cardiovascular disease (Madero et al., 2009; McMurray et al., 2009; O’Seaghdha et al., 2014), and more recently impaired cognition. This evidence concerns the gene CST3 and chronic kidney disease.